Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 440 full-time employees. The company went IPO on 2021-11-02. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
What is the price performance of SMMBF stock?
The current price of SMMBF is $1.68, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Shanghai MicroPort MedBot Group Co Ltd?
Shanghai MicroPort MedBot Group Co Ltd belongs to Health Care industry and the sector is Health Care
What is Shanghai MicroPort MedBot Group Co Ltd market cap?
Shanghai MicroPort MedBot Group Co Ltd's current market cap is $NaN
Is Shanghai MicroPort MedBot Group Co Ltd a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Shanghai MicroPort MedBot Group Co Ltd, including 4 strong buy, 4 buy, 3 hold, 0 sell, and 4 strong sell
